Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 12,500 shares of the stock in a transaction on Thursday, June 11th. The shares were purchased at an average price of $20.00 per share, for a total transaction of $250,000.00. Following the completion of the transaction, the director owned 12,500 shares in the company, valued at approximately $250,000. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.
Parabilis Medicines Stock Performance
NASDAQ PBLS opened at $25.01 on Tuesday. Parabilis Medicines, Inc. has a twelve month low of $24.51 and a twelve month high of $34.47.
See Also
- Five stocks we like better than Parabilis Medicines
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
